Novo Nordisk
NVO
NVO
431 hedge funds and large institutions have $6.47B invested in Novo Nordisk in 2013 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 181 increasing their positions, 122 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
431
Holders Change
+6
Holders Change %
+1.41%
% of All Funds
12.52%
Holding in Top 10
16
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+45.45%
% of All Funds
0.46%
New
52
Increased
181
Reduced
122
Closed
41
Calls
$39M
Puts
$33M
Net Calls
+$6.01M
Net Calls Change
+$700K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$57.6M |
| 2 |
Lazard Asset Management
New York
|
+$44.7M |
| 3 |
WCM Investment Management
Laguna Beach,
California
|
+$30.2M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$29.3M |
| 5 |
Renaissance Technologies
New York
|
+$23.6M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$217M |
| 2 |
Jennison Associates
New York
|
-$80.6M |
| 3 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
-$72.4M |
| 4 |
O
OppenheimerFunds
New York
|
-$61.1M |
| 5 |
JPMorgan Chase & Co
New York
|
-$31.7M |
